T21	Exp 40 63	the inhibitory molecule
T22	Exp 204 215	its ability
T23	Exp 317 322	which
T24	Exp 281 295	the expression
T25	Exp 519 521	it
T26	Exp 464 469	which
T27	Exp 535 539	that
T28	Exp 584 588	that
T29	Exp 651 655	that
T30	Exp 446 460	The mechanisms
T31	Exp 599 613	the activation
T32	Exp 488 502	these proteins
T33	Exp 757 771	the expression
T34	Exp 870 883	The mechanism
T35	Exp 898 913	this activation
T36	Exp 931 939	Our data
T37	Exp 949 953	that
T38	Exp 1376 1395	those encoding p105
T39	Exp 1447 1451	that
T40	Exp 1424 1437	These results
T41	Exp 1543 1555	the pathways
T42	Exp 1663 1671	the role
T43	Exp 1675 1715	this virus-host cell protein interaction
R6	Coref Anaphora:T22 Antecedent:T3
R7	Coref Anaphora:T23 Antecedent:T44
R8	Coref Anaphora:T26 Antecedent:T30
R9	Coref Anaphora:T28 Antecedent:T45
R10	Coref Anaphora:T29 Antecedent:T46
T1	Protein 0 5	LMP-1
T2	Protein 64 79	I kappa B alpha
T3	Protein 82 87	LMP-1
T4	Protein 267 272	LMP-1
T5	Protein 299 303	bcl2
T6	Protein 470 475	LMP-1
T7	Protein 540 545	LMP-1
T8	Protein 863 868	LMP-1
T9	Protein 1076 1081	LMP-1
T10	Protein 1083 1098	I kappa B alpha
T11	Protein 1126 1131	LMP-1
T12	Protein 1177 1192	I kappa B alpha
T13	Protein 1391 1395	p105
T14	Protein 1400 1415	I kappa B alpha
T15	Protein 1417 1421	MAD3
T16	Protein 1452 1457	LMP-1
T17	Protein 1508 1523	I kappa B alpha
T18	Protein 1569 1574	LMP-1
T19	Protein 1623 1638	I kappa B alpha
T44	Exp 305 316	an oncogene
T45	Exp 555 583	signal transduction pathways
T46	Exp 624 650	more transcription factors
